Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 19;8(4):00205-2022.
doi: 10.1183/23120541.00205-2022. eCollection 2022 Oct.

Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa

Affiliations

Development and validation of an interstitial lung disease exposure questionnaire for sub-Saharan Africa

Peter Jackson et al. ERJ Open Res. .

Abstract

Background: American Thoracic Society/European Respiratory Society guidelines recommend context-specific exposure assessments to diagnose interstitial lung disease (ILD). In sub-Saharan Africa, ILD diagnoses are rare, and locally validated ILD exposure questionnaires are not used.

Methods: A physician-administered ILD exposure questionnaire was developed using a four-step mixed-methods modified Delphi approach. First, ILD questionnaires from high-income countries and data from Pneumotox were reviewed, compiled and face-validated. Second, a local pilot group of ILD experts ranked item relevance using a Likert scale and suggested additions. Third, the questionnaire format and pilot rankings were addressed in a focus group discussion that was analysed using grounded theory. Finally, following focus group discussion modifications, the resulting items (with three duplicate item groups for evaluation of internal consistency) were ranked for importance by members of the Pan-African Thoracic Society (PATS).

Results: Face validation resulted in 82 items in four categories: "Smoking and Drugs", "Environmental Exposures", "Occupations" and "Medications". Pilot group (n=10) ranking revealed 27 outliers and 30 novel suggestions. Focus group (n=12) discussion resulted in 10 item deletions, 14 additions and 22 re-wordings; themes included desire for extensive questionnaires and stigma sensitivity. Final validation involved 58 PATS members (mean±sd age 46±10.6 years, 76% male, from 17 countries) ranking 84 items derived from previous steps and three duplicate question groups. The questionnaire was internally consistent (Cronbach's α >0.80) and ultimately included 73 items.

Conclusion: This mixed-methods study included experts from 17 countries in sub-Saharan Africa and successfully developed a 73-item ILD exposure questionnaire for sub-Saharan Africa. African pulmonary experts valued region-specific additions and ranked several items from existing ILD questionnaires as unimportant.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: P. Jackson has nothing to disclose. Conflict of interest: R. Padalkar has nothing to disclose. Conflict of interest: W. Katagira has nothing to disclose. Conflict of interest: K. Mortimer has nothing to disclose. Conflict of interest: N.A. Rykiel has nothing to disclose. Conflict of interest: N.M. Robertson has nothing to disclose. Conflict of interest: S.L. Pollard has nothing to disclose. Conflict of interest: P. Alupo has nothing to disclose. Conflict of interest: W. Checkley has nothing to disclose. Conflict of interest: B. Kirenga has nothing to disclose. Conflict of interest: T. Siddharthan has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Flow diagram of study design and progression of questionnaire development (final questionnaire provided in supplementary material). PATS: Pan-African Thoracic Society.
FIGURE 2
FIGURE 2
Location of respondents. Marker size proportional to number of respondents.

References

    1. Raghu G, Remy-Jardin M, Myers JL, et al. . Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198: e44–e68. doi:10.1164/rccm.201807-1255ST - DOI - PubMed
    1. Olaosebikan H, Adeyeye O, Akintayo R, et al. . Connective tissue disease–associated interstitial lung disease: an underreported cause of interstitial lung disease in sub-Saharan Africa. Clin Rheumatol 2020; 40: 3455–3460. doi:10.1007/s10067-0202-05336-5 - DOI - PubMed
    1. Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Global Health 2019; 85: 4. doi:10.5334/aogh.2414 - DOI - PMC - PubMed
    1. Nightingale R, Lesosky M, Flitz G, et al. . Noncommunicable respiratory disease and air pollution exposure in Malawi (CAPS). A cross-sectional study. Am J Respir Crit Care Med 2019; 199: 613–621. doi:10.1164/rccm.201805-0936OC - DOI - PMC - PubMed
    1. Morell F, Villar A, Montero MÁ. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 2013; 1: 685–694. doi:10.1016/S2213-2600(13)70191-7 - DOI - PubMed

LinkOut - more resources